Skip to content

European pharma industry criticise German comparative medicines pricing

European pharmaceutical companies have stronglycriticised the German Government’s method of pricing medicines which operates by comparing prices in other countries and the prices of generics.

In a statement given by Richard Bergström, the Director-General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) warned that the German Government’s policy of linking prices of new medicines to generics and prices in other countries was being applied in an inflexible and unthoughtful manner and risked having the unintended consequence of putting at risk citizen access to novel treatments.

Mr Bergström particularly drew attention to the price assessment model’s inclusion of Greece within its calculation. EFPIA consider this inappropriatein relation to the special pricing circumstances in operation in Greece at the present time which aimto ensure continued access to medicines by patients during a unique period of Government spending austerity.

More information here
 

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.